Skip to main content Skip to section navigation Skip to footer

Mydecine Innovations Group Inc.

  • Home
  • About
    • Overview
    • Company History
    • Acquisitions
    • Partnerships
    • Leadership Team
    • Board of Directors
    • Research & Development Team
    • Medical, Scientific and Technology Advisory Board
  • Our Approach
    • IP & Drug Development
    • Clinical Trials
    • Technology
  • Drug Supply
    • Investigational Drug Supply
    • Special Access Program
  • News & Media
    • Blog
    • Press Releases
    • In The News
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Results
    • Stock Data
    • SEDAR
    • Governance
    • FAQs
  • Contact
  • Careers
  • Search

Press Releases

News & Media

News & Media

  • Blog
  • Press Releases
  • In The News
Jan 14, 2021 11:28am EST

Mydecine Innovations Group Upsizes Previously Announced Bought Deal

Jan 14, 2021 7:10am EST

Mydecine Innovations Group Announces C$10 Million Bought Deal Offering of Units

Jan 11, 2021 7:30am EST

Mydecine Innovations Group Appoints Gordon Neal to Board of Directors and Dean Ditto as Chief Financial Officer

Jan 07, 2021 7:30am EST

Mydecine Innovations Group Shares Intellectual Property Update

Jan 05, 2021 7:30am EST

Mydecine Innovations Group Sponsors First Lab-Based Study of Established Microdosers at Macquarie University in Australia

Dec 21, 2020 7:30am EST

Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials

Dec 15, 2020 7:30am EST

Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials

Dec 10, 2020 7:30am EST

Mydecine Innovations Group Partners with Microdose Psychedelic Insights to Present a Free, Live Webinar Series on The Renaissance of Psychedelics

Dec 08, 2020 7:30am EST

Mydecine Innovations Group to Make First Commercial Export of Legal Psilocybin Mushrooms

Nov 24, 2020 1:23am EST

Mydecine Innovations Group to Restate Financial Statements

rss_feed News RSS
  • arrow_back
  • 1…
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • arrow_forward

Sign up for our Newsletter!

twitter Linkedin Instagram
©2022 Mydecine Innovations Group Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap